These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmacogenetics of antipsychoatics. Ozaki N Nagoya J Med Sci; 2004 May; 67(1-2):1-7. PubMed ID: 15279062 [TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research. Arranz MJ; de Leon J Mol Psychiatry; 2007 Aug; 12(8):707-47. PubMed ID: 17549063 [TBL] [Abstract][Full Text] [Related]
4. Genetic strategies for the personalization of antipsychotic treatment. Kerwin RW; Mancama DT; Arranz MJ Expert Rev Mol Diagn; 2001 Sep; 1(3):275-80. PubMed ID: 11901832 [TBL] [Abstract][Full Text] [Related]
5. [Pharmacogenetics and tailored drug treatment in schizophrenia]. Andreassen OA; Steen VM Tidsskr Nor Laegeforen; 2006 Sep; 126(18):2400-2. PubMed ID: 16998555 [TBL] [Abstract][Full Text] [Related]
6. [Pharmacogenomics: the quest for individualized therapy]. López-López M; Guerrero-Camacho JL; Familiar-López IM; Jung-Cook H; Corona-Vázquez T; Alonso-Vilatela ME Rev Neurol; 2004 Dec 1-15; 39(11):1063-71. PubMed ID: 15597270 [TBL] [Abstract][Full Text] [Related]
7. [Pharmacogenetics/pharmacogenomics in psychiatry]. Ueda M; Ishiguro S; Watanabe T; Saeki Y; Shimoda K Nihon Rinsho; 2010 Jan; 68(1):155-62. PubMed ID: 20077810 [TBL] [Abstract][Full Text] [Related]
8. The role of 5-HT2C receptor polymorphisms in the pharmacogenetics of antipsychotic drug treatment. Reynolds GP; Templeman LA; Zhang ZJ Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):1021-8. PubMed ID: 15953671 [TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetic studies on the antipsychotic treatment. Current status and perspectives. Gesteira A; Barros F; Martín A; Pérez V; Cortés A; Baiget M; Carracedo A Actas Esp Psiquiatr; 2010; 38(5):301-16. PubMed ID: 21117005 [TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics and the concept of individualized medicine. Shastry BS Pharmacogenomics J; 2006; 6(1):16-21. PubMed ID: 16302022 [TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetic considerations in the treatment of psychiatric disorders. Lohoff FW; Ferraro TN Expert Opin Pharmacother; 2010 Feb; 11(3):423-39. PubMed ID: 20102306 [TBL] [Abstract][Full Text] [Related]
12. Role of CYP pharmacogenetics and drug-drug interactions in the efficacy and safety of atypical and other antipsychotic agents. Murray M J Pharm Pharmacol; 2006 Jul; 58(7):871-85. PubMed ID: 16805946 [TBL] [Abstract][Full Text] [Related]
13. The impact of pharmacogenetics on the development and use of antipsychotic drugs. Reynolds GP Drug Discov Today; 2007 Nov; 12(21-22):953-9. PubMed ID: 17993414 [TBL] [Abstract][Full Text] [Related]
14. Pharmacogenomics of antipsychotics efficacy for schizophrenia. Cacabelos R; Hashimoto R; Takeda M Psychiatry Clin Neurosci; 2011 Feb; 65(1):3-19. PubMed ID: 21265934 [TBL] [Abstract][Full Text] [Related]